Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.84%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
90.15 Up 1.06(1.19%) 12:08PM EDT - Nasdaq Real Time Price
Prev Close:89.09
Open:89.35
Bid:90.40 x 300
Ask:90.52 x 100
1y Target Est:114.68
Beta:1.57024
Earnings Date:Aug 1 - Aug 5 (Est.)
Day's Range:89.35 - 91.25
52wk Range:62.12 - 151.75
Volume:528,600
Avg Vol (3m):1,532,510
Market Cap:14.63B
P/E (ttm):N/A
EPS (ttm):-1.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 1.19%14.63B
FOLDUp 0.71%903.33M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.20
Quarterly EPS Est (Jun-16) :-0.50
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.62

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback